SCHEMBL8934574

SCHEMBL8934574

COc1cccc2c(=O)cc(-c3cccc(C#N)c3)oc12

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.60
▸ CYP3A4 P08684 5/20 0.60
▸ HPGD P15428 5/20 0.60
▸ MAPT P10636 4/20 0.60
▸ KDM4E B2RXH2 4/20 0.60
▸ HSD17B10 Q99714 4/20 0.60
▸ CYP1A1 P04798 5/20 0.50
▸ CYP1B1 Q16678 5/20 0.50
▸ CYP1A2 P05177 4/20 0.50
▸ ABCC1 P33527 2/20 0.50
▸ ABCG2 Q9UNQ0 2/20 0.50
▸ ABCB1 P08183 2/20 0.50
▸ CYP2C9 P11712 2/20 0.50
▸ CYP2C19 P33261 2/20 0.50
▸ CSNK2A2 P19784 1/20 0.47
▸ CSNK2B P67870 1/20 0.47
▸ CSNK2A1 P68400 1/20 0.47
▸ LCK P06239 1/20 0.47
▸ MEN1 O00255 1/20 0.46
▸ GLA P06280 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
8-Methoxyflavone SCHEMBL26180800 0.83 ALDH1A1 (0.74) ALDH1A1CYP3A4HPGDMAPTKDM4E
SCHEMBL8934486 0.81 LCK (0.70) ALDH1A1CYP3A4HPGDMAPTKDM4E
SCHEMBL8934630 0.78 ALDH1A1 (0.60) ALDH1A1CYP3A4HPGDMAPTKDM4E
SCHEMBL311766 0.77 ALDH1A1 (0.66) ALDH1A1CYP3A4HPGDMAPTKDM4E
8,2'-Dimethoxyflavone SCHEMBL516353 0.75 ALDH1A1 (1.00) ALDH1A1CYP3A4HPGDMAPTKDM4E
SCHEMBL11732745 0.73 ALDH1A1 (0.47) ALDH1A1CYP3A4HPGDMAPTKDM4E
SCHEMBL11732750 0.73 ALDH1A1 (0.47) ALDH1A1CYP3A4HPGDMAPTKDM4E
SCHEMBL11737335 0.72 ALDH1A1 (0.46) ALDH1A1CYP3A4HPGDMAPTKDM4E
SCHEMBL28592427 0.71 ALDH1A1 (0.64) ALDH1A1CYP3A4HPGDMAPTKDM4E
SCHEMBL21801245 0.70 ABCB1 (0.58) ALDH1A1CYP3A4HPGDMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996031206-A2 FLAVONES AND COUMARINS AS AGENTS FOR THE TREATMENT OF ATHEROSCLEROSIS WARNER-LAMBERT COMPANY (US) 1996-10-10 — — WO claimed
WO-1996031206-A2 FLAVONES AND COUMARINS AS AGENTS FOR THE TREATMENT OF ATHEROSCLEROSIS WARNER-LAMBERT COMPANY (US) 1996-10-10 — — WO disclosed
Send feedback